Retention Rate of Acalabrutinib in a Non-interventional Setting

Clinical trial NCT05645172 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05645172
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Chronic Lymphocytic Leukaemia (CLL)

Start date: 2022-12-12
Primary completion: 2026-10-15
Enrollment: 137

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.